BioCentury
ARTICLE | Company News

MannKind, Sanofi deal

January 11, 2016 8:00 AM UTC

Sanofi terminated an August 2014 deal with MannKind granting the pharma exclusive, worldwide rights to develop and commercialize Afrezza to treat adults with Type I or II diabetes. Sanofi said the de...